Pentwater Capital Management’s PureTech Health PRTC Stock Holding History

Pentwater Capital Management’s Portfolio PRTC Stock Details PRTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Hold	70,000	–	–	0.01%	78
2025 Q4	$1.16M	Sell	70,000 -5,000	-7%	-$85.8K	0.01%	69
2025 Q3	$1.39M	Buy	75,000 +25,000	+50%	+$439K	0.01%	87
2025 Q2	$863K	Buy	50,000 +16,440	+49%	+$289K	0.01%	84
2025 Q1	$664K	Buy	33,560 +9,449	+39%	+$173K	0.01%	96
2024 Q4	$445K	Sell	24,111 -889	-4%	-$18.6K	﹤0.01%	84
2024 Q3	$515K	Buy	25,000 +8,807	+54%	+$192K	0.01%	86
2024 Q2	$405K	Sell	16,193 -807	-5%	-$22.6K	0.01%	88
2024 Q1	$485K	Buy	17,000 +6,756	+66%	+$173K	0.01%	92
2023 Q4	$289K	Buy	+10,244	New	+$209K	﹤0.01%	104

Other funds holding PRTC

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAP

Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Pentwater Capital Management's PRTC Position: Q1 2026 in Review

Pentwater Capital Management held its PureTech Health (PRTC) position steady in Q1 2026 at 70,000 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #78.

Pentwater Capital Management first reported a position in PRTC in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.39M in Q3 2025. 5 funds tracked by Wall St. Rank hold PRTC as of Q1 2026.

Pentwater Capital Management held 70,000 shares of PureTech Health worth $1.04M as of Q1 2026.
Pentwater Capital Management left its PureTech Health share count unchanged in Q1 2026.
PureTech Health made up 0.01% of Pentwater Capital Management's portfolio in Q1 2026, its #78 holding.
Pentwater Capital Management first reported a position in PureTech Health in Q4 2023 and has held it in 10 quarters since.
Pentwater Capital Management's PureTech Health position peaked at $1.39M in Q3 2025.
5 funds tracked by Wall St. Rank held PureTech Health as of Q1 2026.

Based on Pentwater Capital Management's 13F filing for Q1 2026, filed 15 May 2026.